Blueshift Asset Management’s Novartis NVS Stock Holding History

Blueshift Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,966	Closed	-$200K	–	340
2023 Q3	$200K	Buy	+1,966	New	+$200K	0.12%	249
2022 Q4	–	Sell	-4,565	Closed	-$347K	–	541
2022 Q3	$347K	Sell	4,565 -3,525	-44%	-$292K	0.07%	367
2022 Q2	$684K	Sell	8,090 -4,445	-35%	-$390K	0.11%	265
2022 Q1	$1.1M	Sell	12,535 -43,112	-77%	-$3.73M	0.1%	257
2021 Q4	$4.87M	Buy	55,647 +5,826	+12%	+$484K	0.43%	55
2021 Q3	$4.07M	Buy	49,821 +28,614	+135%	+$2.57M	0.23%	109
2021 Q2	$1.94M	Buy	+21,207	New	+$1.89M	0.11%	225
2019 Q4	–	Sell	-10,350	Closed	-$899K	–	966
2019 Q3	$899K	Buy	10,350 +7,695	+290%	+$691K	0.14%	214
2019 Q2	$242K	Buy	+2,655	New	+$225K	0.03%	614
2019 Q1	–	Sell	-10,676	Closed	-$821K	–	865
2018 Q4	$821K	Buy	+10,676	New	+$831K	0.15%	205

Other funds holding NVS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Blueshift Asset Management's NVS Position: Q4 2023 in Review

Blueshift Asset Management sold out of Novartis (NVS) in Q4 2023, closing a stake of 1,966 shares — an estimated $200K sold.

Blueshift Asset Management first reported a position in NVS in Q4 2018 and held it in 10 quarters. The position peaked at $4.87M in Q4 2021. 1,272 funds tracked by Wall St. Rank hold NVS as of Q4 2023.

Blueshift Asset Management reported no remaining Novartis position as of Q4 2023 after selling out during the quarter.
Blueshift Asset Management sold 1,966 Novartis shares in Q4 2023, an estimated $200K.
Blueshift Asset Management first reported a position in Novartis in Q4 2018 and held it in 10 quarters.
Blueshift Asset Management's Novartis position peaked at $4.87M in Q4 2021.
1,272 funds tracked by Wall St. Rank held Novartis as of Q4 2023.

Based on Blueshift Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.